You have 1 action to finish to complete your account. Craft your experience by picking your interest on the Personalisation Page
Pulmonology

Eosinophils as a Biomarker for Type 2 Asthma

Dr. Elliot Israel presents the utility of eosinophils as a biomarker of type 2 inflammation and their role in the disease burden of asthma.

Elliot Israel
MD
Elliot Israel

Learning objectives

  • Understand the role of eosinophils as a diagnostic, predictive, and prognostic marker of severe asthma

Description

Elliot Israel, MD, discusses the diagnostic, predictive, and prognostic role of eosinophils as a biomarker of type 2 inflammation in asthma.

MAT-US-2207246 v2.0 P - Exp. Date 10/25/2024

About this expert

Pulmonology

Elliot Israel

MD

Director of the Respiratory Therapy Department, Director of Clinical Research in the Pulmonary and Critical Care Medicine Division, Gloria M. and Anthony C. Simboli and Distinguished Chair in Asthma Research | Brigham and Women’s Hospital, Boston, United States

See author’s profile
Elliot Israel

Related resources